PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • Advertisement
  • FDA Date: 09/20/2015

    Victoza (liraglutide) Injection REMS

    Goal of the Victoza (liraglutide) Injection REMS Program

    The goal of the VICTOZA REMS is to mitigate the potential risk of medullary thyroid carcinoma and the risk of acute pancreatitis (including necrotizing pancreatitis) associated with VICTOZA by:

    • Informing healthcare providers about the potential risk of medullary thyroid carcinoma and the risk of acute pancreatitis (including necrotizing pancreatitis) associated with VICTOZA.

    REMS Elements

    • Communication Plan